Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1993;13:1317-1326

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller, G.
Right arrow Articles by Schmitz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, G.
Right arrow Articles by Schmitz, G.

Arteriosclerosis and Thrombosis, Vol 13, 1317-1326, Copyright © 1993 by American Heart Association


ARTICLES

Effects of purinergic agents on human mononuclear phagocytes are differentiation dependent. Implications for atherogenesis

G Muller, C Kerkhoff, J Hankowitz, M Pataki, E Kovacs, KJ Lackner and G Schmitz
Institut fur Klinische Chemie und Laboratoriumsmedizin, Universitat Regensburg, Germany.

The differentiation-dependent expression of purinergic receptors for metabolically stable analogues of adenosine and ATP was studied in human mononuclear phagocytes (MNPs). Ligands of these receptors are able to modulate cellular cholesterol metabolism. In addition, the intracellular signal transduction pathways of the purinergic receptor system were examined. ATP gamma S, the metabolic stable analogue of ATP, was used as a P2 ligand, and 2-p-(2-carboxyethyl)phenylethylamino- 5'-N-ethylcarboxamido adenosine (CGS 21680) and 5'-(N- ethylcarboxamido)adenosine (NECA) were used as P1 ligands in binding studies. Binding of [35S]ATP gamma S to MNPs at 4 degrees C revealed saturable low-affinity binding sites with a Kd of 868 +/- 52 nmol/L and Bmax of 7.3 +/- 0.4 pmol per 10(6) cells in 1-day cultured human MNPs and a Kd of 780 +/- 30 nmol/L and Bmax of 14.0 +/- 0.8 pmol per 10(6) cells in 7-day cultured human MNPs. The characterization of the P1 receptors on 1- and 7-day cultured human MNPs showed that they are expressed only on 7-day cultured human MNPs. The specific binding curve of the adenosine A2 receptor agonist [3H]CGS 21680 was biphasic, with a Kd1 of 33 +/- 15 nmol/L and a Kd2 of 90 +/- 10 nmol/L and with Bmax1 of 0.19 +/- 0.06 pmol per 10(6) cells and Bmax2 of 0.41 +/- 0.09 pmol per 10(6) cells, whereas NECA did not exhibit specific binding. The typical agonists for probing A1 receptor subtypes did not bind to 1- and 7-day cultured human MNPs, indicating that only A2 receptors are expressed on 7-day cultured human MNPs. ATP gamma S enhanced [Ca2+]i in 1- and 7-day cultured human MNPs in a concentration-dependent manner, whereas the P1 ligands, adenosine and CGS 21680, induced Ca2+ flux only in 7-day cultured MNPs. All three drugs increased intracellular cAMP levels in 7- day cultured human MNPs at a concentration of 10(-5) mol/L, whereas no effect was observed in 1-day cultured human MNPs. The uptake of fluorescently labeled acetylated low-density lipoprotein (LDL) in 7-day cultured human MNPs was inhibited by adenosine, CGS 21680, ATP, and ATP gamma S. No significant influence of these compounds was measured on the uptake of LDL, acetylated LDL, and high-density lipoprotein, in 1- day cultured MNPs. Our investigations indicate that the expression of P2y and A2 receptors is increased during differentiation of blood monocytes to macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Ghavami, C. Kerkhoff, M. Los, M. Hashemi, C. Sorg, and F. Karami-Tehrani
Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions
J. Leukoc. Biol., July 1, 2004; 76(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. I. Seye, Q. Kong, L. Erb, R. C. Garrad, B. Krugh, M. Wang, J. T. Turner, M. Sturek, F. A. Gonzalez, and G. A. Weisman
Functional P2Y2 Nucleotide Receptors Mediate Uridine 5'-Triphosphate-Induced Intimal Hyperplasia in Collared Rabbit Carotid Arteries
Circulation, November 19, 2002; 106(21): 2720 - 2726.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Kerkhoff, H. A. Hofmann, J. Vormoor, H. Melkonyan, J. Roth, C. Sorg, and M. Klempt
Binding of Two Nuclear Complexes to a Novel Regulatory Element within the Human S100A9 Promoter Drives the S100A9 Gene Expression
J. Biol. Chem., October 25, 2002; 277(44): 41879 - 41887.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kapinsky, M. Torzewski, C. Buchler, C. Q. Duong, G. Rothe, and G. Schmitz
Enzymatically Degraded LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36
Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 1004 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Kerkhoff, M. Klempt, V. Kaever, and C. Sorg
The Two Calcium-binding Proteins, S100A8 and S100A9, Are Involved in the Metabolism of Arachidonic acid in Human Neutrophils
J. Biol. Chem., November 12, 1999; 274(46): 32672 - 32679.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Stohr, G. Schindler, G. Rothe, and G. Schmitz
Enhanced Upregulation of the Fc{gamma} Receptor IIIa (CD16a) During In Vitro Differentiation of ApoE4/4 Monocytes
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1424 - 1432.
[Abstract] [Full Text] [PDF]